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Fig. 6. Bar graph and representative immunoblot showing the eﬀect of imatinib (IMTB), curcumin (CURC) and cyclosporine plus rapamycin
(Cy + Ra) on smoothelin expression in S-SMCs. Imatinib drastically increases smoothelin expression compared with control condition while the
other treatments have no eﬀect. **P < 0.01.
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